Physician profile
Michelle R Sitzman
NPI 1568469419
$206,267.54
in general payments reported to CMS, 2019-2025
24 companies · $108K in 2025
The $108K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,572 · 2022: $5,660 · 2023: $39K · 2024: $53K · 2025: $108K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113K · Consulting Fee: $35K · Travel and Lodging: $35K · Food and Beverage: $12K · Honoraria: $3,575 · Education: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113,465.36 |
| Consulting Fee | $35,412.50 |
| Travel and Lodging | $34,590.80 |
| Food and Beverage | $11,560.32 |
| Honoraria | $3,575.00 |
| Education | $431.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $52,979.91 | 2023-2025 | Zoryve |
| Incyte Corporation | $38,379.29 | 2021-2025 | Opzelura, Opzelura |
| Regeneron Healthcare Solutions, INC. | $36,207.44 | 2021-2025 | Dupixent |
| Abbvie INC. | $28,642.39 | 2021-2025 | |
| Galderma Laboratories, L.P. | $24,958.94 | 2021-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $10,667.83 | 2022-2025 | |
| Organon LLC | $5,239.08 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $1,888.55 | 2024 | Ycanth |
| Kowa Pharmaceuticals America, INC. | $1,680.64 | 2025 | Zoryve |
| Ucb, INC. | $1,053.27 | 2021-2025 | Bimzelx, Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $780.93 | 2021-2025 | Jublia, Arazlo, Cabtreo |
| Lilly USA, LLC | $653.09 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $619.11 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $551.98 | 2022-2025 | Sotyktu, Sprycel |
| Sun Pharmaceutical Industries INC. | $494.59 | 2021-2025 | Ilumya |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $314.73 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $310.37 | 2021-2023 | Tremfya |
| Leo Pharma INC. | $280.52 | 2022-2025 | Adbry, Anzupgo |
| Janssen Scientific Affairs, LLC | $215.63 | 2021-2022 | |
| Pfizer INC. | $124.71 | 2023-2025 | |
| Regeneron Pharmaceuticals, INC. | $108.85 | 2023-2025 | Dupixent |
| Amgen INC. | $57.11 | 2021-2025 | Otezla, Otezla |
| Ani Pharmaceuticals, INC. | $36.37 | 2025 | Purified Cortrophin Gel |
| Botanix Sb INC | $22.21 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Sitzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.